Activity tracked lower mortality, evidence very weak

Prostate cancer is highly prevalent and carries substantial morbidity and mortality, so men diagnosed with it, or at raised risk, often ask whether staying active changes their outlook. Physical activity has already been linked to lower risk of developing the disease, and exercise has been shown to reduce mortality more broadly, but the specific association between activity and death in this group has been less clearly mapped. Pulling the observational literature together also tests how good that evidence actually is. The review set out to grade it rather than simply count positive findings.

The authors searched Medline, Scopus and Web of Science from inception to April 2026 for observational studies relating physical activity to all-cause and prostate-cancer-specific mortality in men with or at risk of prostate cancer. Fifteen studies met the criteria. Because of variation in exposure measurement and design, results were combined using a synthesis without meta-analysis (SWiM) approach rather than pooled statistically. Study quality was appraised with the NHLBI tool and the overall certainty of evidence was rated using the GRADE framework. The hazard ratio was the predominant effect measure reported across the included cohorts.

Physical activity was associated with reduced all-cause mortality, with hazard ratios between 0.40 and 0.88 when the highest activity categories were compared with the lowest. A dose-response gradient - more activity, lower risk - was observed within two of the cohorts. Associations with prostate-cancer-specific mortality were less consistent, and the significant inverse findings clustered in studies that measured activity after diagnosis rather than before. Study quality was generally poor and GRADE certainty was very low for both mortality outcomes, including for the dose-response signal.

The review is consistent with the broader observational literature linking activity to lower all-cause mortality, but it also complicates the story by showing how thin the disease-specific evidence is. The concentration of inverse findings in post-diagnosis measurements is interesting yet vulnerable to reverse causation: men who are already sicker move less. Very low certainty means future, better-designed studies could shift the estimates substantially. The authors call for prospective studies using standardised, objective measures of physical activity.

This is a reason to think activity is associated with better overall survival in men living with or at risk of prostate cancer, but not a reason to treat any activity level as a treatment. The wide spread of hazard ratios reflects heterogeneous, mostly self-reported exposure data rather than a precisely known effect. Anyone in this clinical situation is dealing with decisions that belong with their own medical team. The broader takeaway is how often a headline-friendly association rests on evidence the reviewers themselves grade as very low certainty.